Edges in Network
| Network | GSE25066_egf1520 - GSE25066 - SiGN-BN HC+Bootstrap |
| Network Description | Genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | ADAM10 |
| Upstream (Parents) |
|---|
| (<<) ATF2 → ADAM10 |
| (<<) BZW1 → ADAM10 |
| (<<) CEND1 → ADAM10 |
| (<<) CREB1 → ADAM10 |
| (<<) CSGALNACT2 → ADAM10 |
| (<<) CSNK1A1 → ADAM10 |
| (<<) DAZAP2 → ADAM10 |
| (<<) DHX9 → ADAM10 |
| (<<) DVL1 → ADAM10 |
| (<<) ELF1 → ADAM10 |
| (<<) ENO1 → ADAM10 |
| (<<) GAPDH → ADAM10 |
| (<<) GNG4 → ADAM10 |
| (<<) GYS1 → ADAM10 |
| (<<) HSPA8 → ADAM10 |
| (<<) KIAA0020 → ADAM10 |
| (<<) MAP3K7 → ADAM10 |
| (<<) MAT2A → ADAM10 |
| (<<) MCL1 → ADAM10 |
| (<<) PRPF4B → ADAM10 |
| (<<) PTGER1 → ADAM10 |
| (<<) RAB5A → ADAM10 |
| (<<) RHOA → ADAM10 |
| (<<) RNF111 → ADAM10 |
| Downstream (Children) |
|---|
| ADAM10 → ADAM9 (>>) |
| ADAM10 → ATF4 (>>) |
| ADAM10 → B3GNT2 (>>) |
| ADAM10 → CARD9 (>>) |
| ADAM10 → CASP8 (>>) |
| ADAM10 → CPD (>>) |
| ADAM10 → CYP2U1 (>>) |
| ADAM10 → DUSP6 (>>) |
| ADAM10 → ENTPD7 (>>) |
| ADAM10 → ERBB2 (>>) |
| ADAM10 → EVX1 (>>) |
| ADAM10 → F2RL1 (>>) |
| ADAM10 → FAM48A (>>) |
| ADAM10 → GNA13 (>>) |
| ADAM10 → GNB5 (>>) |
| ADAM10 → GSK3B (>>) |
| ADAM10 → HGS (>>) |
| ADAM10 → IL1F9 (>>) |
| ADAM10 → INF2 (>>) |
| ADAM10 → INPPL1 (>>) |
| ADAM10 → ITGB6 (>>) |
| ADAM10 → KHDRBS1 (>>) |
| ADAM10 → KLF6 (>>) |
| ADAM10 → MAP3K1 (>>) |
| ADAM10 → MAP3K11 (>>) |
| ADAM10 → MAP3K5 (>>) |
| ADAM10 → MAP3K8 (>>) |
| ADAM10 → MMP28 (>>) |
| ADAM10 → MT3 (>>) |
| ADAM10 → NOTCH2 (>>) |
| ADAM10 → PDIA3 (>>) |
| ADAM10 → PIK3CA (>>) |
| ADAM10 → PLA2R1 (>>) |
| ADAM10 → PRKCI (>>) |
| ADAM10 → RHOQ (>>) |
| ADAM10 → STAT6 (>>) |
| ADAM10 → SULT4A1 (>>) |
| ADAM10 → T (>>) |
| ADAM10 → TAF1A (>>) |
| ADAM10 → TP53 (>>) |
